Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis

Background: The clinical course of multiple sclerosis ranges from benign with little disease progression and minimal disability, to severe disease requiring intensive medical treatment. There are no reliable circulating biomarkers for predicting disease outcome. Co-inhibitory receptors regulate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavon, Iris, Heli, Coral, Brill, Livnat, Charbit, Hanna, Vaknin-Dembinsky, Adi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524709/
https://www.ncbi.nlm.nih.gov/pubmed/31134049
http://dx.doi.org/10.3389/fimmu.2019.00835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524709/
https://www.ncbi.nlm.nih.gov/pubmed/31134049
http://dx.doi.org/10.3389/fimmu.2019.00835

Ejemplares similares